巴西原发性醛固酮增多症队列中醛固酮瘤与结节的体细胞驱动基因突变谱
该研究纳入巴西61例原发性醛固酮增多症患者的62个经典组织学病变,分析体细胞驱动基因突变。结果发现82.26%病变携带已知致病突变,KCNJ5最常见(56.45%),ATP2B3突变频率(11.29%)显著高于其他种族队列(4.06%)。ATP2B3突变肿瘤多见于老年男性且体积较小。
要点
- 巴西原发性醛固酮增多症病变中体细胞驱动突变检出率达82.26%,以KCNJ5为主。
- ATP2B3突变频率为11.29%,显著高于其他种族队列的4.06%。
- ATP2B3突变肿瘤多见于老年男性,且体积较野生型肿瘤小。
核心结论
- 巴西原发性醛固酮增多症队列中已知体细胞驱动突变占主导,且ATP2B3突变频率显著高于其他种族队列。
研究设计与样本
- 研究纳入61例原发性醛固酮增多症患者的62个经典组织学病变(含1例双侧醛固酮瘤),中位诊断年龄49岁,59%为女性。
- 对优势病变CYP11B2阳性区域提取体细胞DNA,先对KCNJ5、ATP1A1、ATP2B3、CACNA1D和CTNNB1热点区域行Sanger测序,无驱动变异者行配对体细胞与胚系全外显子测序。
主要发现
- 组织病理学显示醛固酮瘤合并醛固酮产生微结节最常见(n=29,47.54%),其次为孤立醛固酮瘤(n=20,32.79%)和醛固酮产生结节(n=5,8.2%)。
- 82.26%病变检出体细胞致病变异:KCNJ5(n=35,56.45%)、ATP2B3(n=7,11.29%)、CACNA1D(n=5,8.06%)、ATP1A1(n=4,6.45%)。
- 鉴定出9个新变异,包括ATP2B3 3个(2个外显子8框内缺失和1个错义)、KCNJ5 3个、CACNA1D 2个和CTNNB1 1个。
- ATP2B3变异频率(11.29%)显著高于其他种族队列报告的4.06%(p=.0053)。
- 3例患者检出罕见胚系CACNA1H变异。
临床怎么用
- 在巴西人群中检测原发性醛固酮增多症病变的体细胞驱动基因时,应关注ATP2B3突变较高的频率。
- ATP2B3突变肿瘤的临床特征(老年男性、体积较小)可辅助术前评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Brazilian population represents a mosaic of genetic diversity resulting from admixture ancestries. Given reported disparities in primary aldosteronism (PA) genetics across ethnicities, we investigated the genetic spectrum of aldosterone-producing adenomas (APAs) and nodules (APNs) with classical histology in a Brazilian cohort. METHODS: We included 62 lesions (1 case with bilateral APAs) from 61 consecutive patients (median age at PA diagnosis 49 years, 59% women) with PA and classical histology, defined by CYP11B2 immunostaining (HISTALDO consensus). Somatic DNA was extracted from CYP11B2-positive areas of the dominant lesions. Hotspot regions of KCNJ5, ATP1A1, ATP2B3, CACNA1D, and CTNNB1 were initially analyzed by Sanger sequencing. Whole-exome sequencing of paired somatic and germline DNA was subsequently performed in cases without driver variants. RESULTS: Histopathology showed combined APA + aldosterone-producing micronodules as the most frequent subtype (n = 29, 47.54%), followed by isolated APA (n = 20, 32.79%) and APN (n = 5, 8.2%). Somatic pathogenic variants were identified in 82.26% of lesions: KCNJ5 (n = 35, 56.45%), ATP2B3 (n = 7, 11.29%), CACNA1D (n = 5, 8.06%), and ATP1A1 (n = 4, 6.45%). Nine novel variants were identified, including 3 in ATP2B3 (2 exon 8 in-frame deletions and 1 missense), 3 in KCNJ5, 2 in CACNA1D, and 1 in CTNNB1. The frequency of ATP2B3 variants (11.29%) was significantly higher than that reported in other cohorts (4.06%) from different ethnicities (p = .0053). ATP2B3-mutated tumors occurred predominantly in older men and were smaller in size compared with wild-type tumors. Rare germline CACNA1H variants were also detected in 3 patients. CONCLUSION: We confirmed the predominance of known somatic drivers and identified a uniquely high frequency of ATP2B3 variants, refining their clinical phenotype. These findings underscore the influence of population-specific genetic backgrounds and expand the global understanding of PA genetics.
引用
- Guimaraes AG, Goldbaum TS, Ledesma FL, et al. Somatic Drivers in Aldosterone-producing Adenomas and Nodules: Insights from a Brazilian Cohort of Primary Aldosteronism. J Clin Endocrinol Metab. 2026. PMID: 41498208. doi:10.1210/clinem/dgag002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。